LCK and central nervous system cancer: Previous studies reported that LCK is an oncogene and the use of LCK inhibitors can inhibit glioma growth, metastasis and the expression of cell stemness-related genes [37], and enhance cisplatin sensitivity in ovarian cancer [38].